Cargando…

Polypeptide Expression in Prostate Hyperplasia and Prostate Adenocarcinoma

Cells were collected from prostate hyperplasias (n=6) and prostate carcinomas (n=6) and subjected to two‐dimensional gel electrophoresis (2‐DE). The resulting polypeptide patterns were analysed with the PDQUEST computer software. Malignant tumors showed significant increases in the level of expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alaiya, Ayodele, Roblick, Uwe, Egevad, Lars, Carlsson, Adelaide, Franzén, Bo, Volz, Daniela, Huwendiek, Sören, Linder, Stig, Auer, Gert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2000
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618420/ https://www.ncbi.nlm.nih.gov/pubmed/11254220 http://dx.doi.org/10.1155/2000/351963

Ejemplares similares

Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins.
por: Franzén, B., et al.
Publicado: (1996)

Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma.
por: Hirano, T., et al.
Publicado: (1995)

Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia.
por: Bentley, H., et al.
Publicado: (1992)

Expression of tropomyosin isoforms in benign and malignant human breast lesions.
por: Franzén, B., et al.
Publicado: (1996)

Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia.
por: Hamdy, F. C., et al.
Publicado: (1994)

Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomy
por: Eslami, Mansooreh, et al.
Publicado: (2016)

Multivariate meta-analysis of proteomics data from human prostate and colon tumours
por: Rosenberg, Lina Hultin, et al.
Publicado: (2010)

Comparing the Immunoexpression of FUT3 and FUT6 between Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia
por: de Albuquerque Vasconcelos, Juliana Lúcia, et al.
Publicado: (2013)

Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies
por: Egevad, Lars, et al.
Publicado: (2021)

Benign Prostatic Hyperplasia
Publicado: (2015)

Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin
por: Lindh, Claes, et al.
Publicado: (2022)

Effect of Comorbidity on Prostate Cancer–Specific Mortality: A Prospective Observational Study
por: Rajan, Prabhakar, et al.
Publicado: (2017)

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study
por: Samir Sayed, Rasha Mohamed, et al.
Publicado: (2023)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma
por: Midi, Ahmet, et al.
Publicado: (2008)

Inhibition of signaling downstream of beta‐2 adrenoceptor by propranolol in prostate cancer cells
por: Alaskar, Aljoharah, et al.
Publicado: (2022)

Prostatic Stromal Hyperplasia with Atypia
por: Hutchinson, Ryan C., et al.
Publicado: (2013)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

The current status of renal cell carcinoma and prostate carcinoma grading
por: Delahunt, Brett, et al.
Publicado: (2018)

FOXP3(+) regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer
por: Davidsson, Sabina, et al.
Publicado: (2017)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer
por: Elkahwaji, Johny E
Publicado: (2012)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Rare Variant of Carcinoma Prostate Masquerading as Benign Prostatic Hyperplasia
por: Khanduri, Sachin, et al.
Publicado: (2019)

Prostate sarcomas: A radiological mimic for benign prostatic hyperplasia
por: Whish-Wilson, Thomas, et al.
Publicado: (2020)

Prostate embolization in the treatment of benign prostatic hyperplasia: what’s the point?
por: Nunes, Thiago Franchi, et al.
Publicado: (2021)

Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
por: Ratajczak, Weronika, et al.
Publicado: (2022)

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022)

Intraductal carcinoma of the prostate: a critical re-appraisal
por: Varma, Murali, et al.
Publicado: (2019)

The Symptoms of Benign Prostatic Hyperplasia Patients with Stromal-Dominated Hyperplasia Nodules May Be Associated with Prostate Fibrosis
por: Cao, Ying, et al.
Publicado: (2023)

Transurethral balloon dilatation of the Prostate and Transurethral Plasmakinetic resection of the Prostate in the treatment of Prostatic Hyperplasia
por: Chang, Yanhua, et al.
Publicado: (2018)

Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia
por: Radwan, Ahmed, et al.
Publicado: (2020)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Oxidative stress in prostate hyperplasia and carcinogenesis
por: Udensi, Udensi K., et al.
Publicado: (2016)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9bk2cj3gabjn8ts4sruuqjfcco